![Camilla Huse Bondesson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Camilla Huse Bondesson
Director/Board Member at
GENETIC ANALYSIS
Profile
Camilla Huse Bondesson is currently the Chairman at Immuneed AB since 2014, Chairman at Tdb Consultancy AB since 2018, Chairman at Tdb Labs AB, Director at 2cureX ApS since 2019, and Director at Genetic Analysis AS since 2020.
Previously, he served as Chairman at Gradientech AB, Independent Director at 2cureX AB from 2019 to 2024, Marketing Director at Cytiva Sweden Holding AB, Vice President-Marketing at Gyros AB, Manager-International Product at Biacore AB, General Manager at Behring Diagnostica AB, Partner at Conlega AB, and Marketing Manager at Global Life Sciences Solutions USA LLC.
He holds an MBA from the University of Stockholm.
Camilla Huse Bondesson active positions
| Companies | Position | Start |
|---|---|---|
| GENETIC ANALYSIS | Director/Board Member | 2019-12-31 |
Immuneed AB
 Immuneed AB Medical SpecialtiesHealth Technology Develops drugs | Chairman | 2014-09-30 |
2cureX ApS
 2cureX ApS Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs and technology for the treatment of cancer | Director/Board Member | 2018-12-31 |
Tdb Consultancy AB | Chairman | 2018-09-30 |
Tdb Labs AB
 Tdb Labs AB BiotechnologyHealth Technology Develops, produces and analyses dextran derivatives & other polysaccharides | Chairman | - |
Former positions of Camilla Huse Bondesson
| Companies | Position | End |
|---|---|---|
| 2CUREX AB | Director/Board Member | 2024-01-03 |
Global Life Sciences Solutions USA LLC
 Global Life Sciences Solutions USA LLC Pharmaceuticals: MajorHealth Technology Manufactures therapeutics | Sales & Marketing | - |
Cytiva Sweden Holding AB
 Cytiva Sweden Holding AB Financial ConglomeratesFinance Provides investment and real estate services | Sales & Marketing | - |
Behring Diagnostica AB | Corporate Officer/Principal | - |
| ░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Camilla Huse Bondesson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
47
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Gyros AB
 Gyros AB Medical SpecialtiesHealth Technology Engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays | Health Technology |
University of Stockholm
 University of Stockholm Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs and technology for the treatment of cancer | Health Technology |
Biacore AB | |
Conlega AB
 Conlega AB Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Genetic Analysis AS
 Genetic Analysis AS Medical SpecialtiesHealth Technology Develops in-vitro diagnostics tests in diseases where microbiota is involved | Health Technology |
Global Life Sciences Solutions USA LLC
Global Life Sciences Solutions USA LLC Pharmaceuticals: MajorHealth Technology Manufactures therapeutics | Health Technology |
Gradientech AB
 Gradientech AB Medical SpecialtiesHealth Technology Provides ultra-rapid antibiotic susceptibility testing services | Health Technology |
Immuneed AB
Immuneed AB Medical SpecialtiesHealth Technology Develops drugs | Health Technology |
2cureX AB
 2cureX AB Medical SpecialtiesHealth Technology Develops and supplies in vitro diagnostic (IVD) devices | Health Technology |
Cytiva Sweden Holding AB
Cytiva Sweden Holding AB Financial ConglomeratesFinance Provides investment and real estate services | Finance |
Tdb Consultancy AB | |
Behring Diagnostica AB | |
Tdb Labs AB
Tdb Labs AB BiotechnologyHealth Technology Develops, produces and analyses dextran derivatives & other polysaccharides | Health Technology |
- Stock Market
- Insiders
- Camilla Huse Bondesson
